A man and a woman with a rare and devastating autoimmune disease have been in remission for more than 15 years after receiving a stem-cell transplant
Source
Twitter / XA man and a woman with a rare and devastating autoimmune disease have been in remission for more than 15 years after receiving a stem-cell transplantgo.nature.comYou might also wanna read
Paediatric autoimmunity: Understanding shared vulnerability and disease co-occurrence in children
This article discusses paediatric autoimmunity, explaining how autoimmune diseases arise from a breakdown of adaptive immune tolerance. It r
Experimental immune reset treatment puts lupus into remission in early UK trials
An experimental treatment that resets the immune system has put lupus into remission in early UK trials. The approach, which could potential
bbc.com·11d ago
Seventh Person Cured of HIV Through Stem Cell Transplant, Second Without HIV-Resistant Cells
A man has become the seventh person to be cured of HIV after receiving a stem cell transplant for blood cancer treatment. Significantly, he
newscientist.com·6mo ago
Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus
This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce
lupus.bmj.com·11d ago
Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time
For the first time, researchers have successfully implanted Crispr-edited pancreatic cells into a patient with type 1 diabetes. The gene-edi
wired.com·9mo ago:max_bytes(150000):strip_icc():focal(749x0:751x2)/Mother-with-Lupus-Gets-Kidney-from-Daughter4-050826-5dffe5459cc44e95827817c64ee3ca15.jpg)
Woman with Lupus-Related Kidney Failure Receives Life-Saving Donation from Her Daughter, an EMT
A 70-year-old woman with lupus, Curlean Phillips, experienced kidney failure requiring grueling dialysis treatment. Her daughter, Chanda Cas
People.com·1mo agoComments
Sign in to join the conversation.
No comments yet. Be the first.